 Multimodal therapy management localized Ewing sarcoma pelvic sacral bones report second intergroup study total eligible patients localized Ewing sarcoma pelvic sacral bones multimodal Intergroup Ewing Sarcoma Study IESS-II historical control series patients multimodal Intergroup Ewing Sarcoma Study IESS-I High-dose intermittent multiagent chemotherapy vincristine cyclophosphamide Adriamycin doxorubicin Adria Columbus OH dactinomycin patients weeks weeks local therapy patients tumor biopsy incomplete resection dose Gy tumor bed median follow-up time years patients local recurrence patients local recurrence metastases patients metastases significant statistical evidence advantage relapse-free survival RFS survival patients IESS-II versus IESS-I years comparison IESS-II IESS-I RFS